VolitionRx Limited Increase (Decrease) in Deferred Revenue
VolitionRx Limited (VNRX) reported Increase (Decrease) in Deferred Revenue of -$889.30 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-13
- VolitionRx Limited increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was -$176.26K.
- VolitionRx Limited increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was -$713.04K.
- VolitionRx Limited increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was -$88.46K.
- VolitionRx Limited increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was -$405.07K.
- VolitionRx Limited increase (decrease) in deferred revenue for fiscal 2025 was -$601.09K.
- VolitionRx Limited increase (decrease) in deferred revenue for fiscal 2024 was -$106.60K, a 100.82% decline from fiscal 2023.
- VolitionRx Limited increase (decrease) in deferred revenue for fiscal 2023 was $13.00M, a 30.16% increase from fiscal 2022.
- VolitionRx Limited increase (decrease) in deferred revenue for fiscal 2022 was $9.99M, a 79723.27% increase from fiscal 2021.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$176.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$889.30K 10-Q · filed 2026-08-13 | -$977.77K derived: sum of 3 quarters · filed 2026-08-13 | -$1.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$713.04K 10-Q · filed 2026-05-14 | -$801.50K derived: sum of 2 quarters · filed 2026-05-14 | -$1.21M derived: sum of 3 quarters · filed 2026-05-14 | -$1.31M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$88.46K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$493.53K derived: sum of 2 quarters · filed 2026-03-31 | -$601.09K derived: sum of 3 quarters · filed 2026-08-13 | -$601.09K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$405.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$512.63K derived: sum of 2 quarters · filed 2026-08-13 | -$512.63K 10-Q · filed 2025-11-13 | -$512.63K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$107.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$107.56K 10-Q · filed 2026-08-13 | -$107.56K derived: sum of 3 quarters · filed 2026-08-13 | -$152.56K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | -$45.00K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$45.00K derived: sum of 2 quarters · filed 2026-03-31 | -$106.60K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$106.60K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$61.60K 10-Q · filed 2025-08-14 | |||
| 2023-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $13.00M derived: sum of 2 quarters · filed 2025-03-31 | $13.00M derived: sum of 3 quarters · filed 2025-03-31 | $13.00M 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-08-14 | $0.00 derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | $0.00 derived: sum of 3 quarters · filed 2024-03-25 | -$12.51K derived: sum of 4 quarters · filed 2024-03-25 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | -$12.51K derived: sum of 3 quarters · filed 2024-03-25 | $9.99M 10-K · filed 2024-03-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$12.51K derived: sum of 2 quarters · filed 2023-11-14 | $9.99M 10-Q · filed 2023-11-14 | $10.00M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$12.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $9.99M 10-Q · filed 2023-08-14 | $10.00M derived: sum of 3 quarters · filed 2023-08-14 | $10.00M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $10.00M 10-Q · filed 2023-05-10 | $10.01M derived: sum of 2 quarters · filed 2023-05-10 | $10.01M derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | $12.51K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $12.51K derived: sum of 2 quarters · filed 2023-03-15 | $12.51K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |